ES2085950T3 - Derivados del acido 1,4-benzotiazina-2-acetico, procedimientos para su produccion y su uso. - Google Patents

Derivados del acido 1,4-benzotiazina-2-acetico, procedimientos para su produccion y su uso.

Info

Publication number
ES2085950T3
ES2085950T3 ES91122330T ES91122330T ES2085950T3 ES 2085950 T3 ES2085950 T3 ES 2085950T3 ES 91122330 T ES91122330 T ES 91122330T ES 91122330 T ES91122330 T ES 91122330T ES 2085950 T3 ES2085950 T3 ES 2085950T3
Authority
ES
Spain
Prior art keywords
elevated
group
low
same
atome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91122330T
Other languages
English (en)
Inventor
Tomoji Aotsuka
Hiroshi Hosono
Toshio Kurihara
Yoshiyuki Nakamura
Tetsuo Matsui
Fujio Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Senju Pharmaceutical Co Ltd
Green Cross Corp
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd, Green Cross Corp, Green Cross Corp Korea filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2085950T3 publication Critical patent/ES2085950T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

DERIVADOS DEL ACIDO DE 1,4-BENZOTIAZINA REPRESENTADOS POR LA FORMULA GENERAL (I) A CONTINUACION: DONDE R ELEVADO 1 REPRESENTA UN GRUPO MOSTRADO POR LAS FORMULAS GENERALES (II) Y (III): DONDE R ELEVADO 5 Y R ELEVADO 6, QUE PUEDEN SER LAS MISMAS O DISTINTAS, REPRESENTAN CADA UNA UN ATOMO DE HIDROGENO O DE HALOGENO, UN GRUPO ALCALINO BAJO, UN GRUPO ALKOXILO BAJO, TRIFLUOROMETILO O CIANO; DONDE R ELEVADO 7, R ELEVADO 9 Y R ELEVADO 10, PODRAN SER LAS MISMAS O DISTINTAS, CADA UNA REPRESENTA UN ATOMO DE HIDROGENO O DE HALOGENO, UN GRUPO ALCALINO BAJO, UN GRUPO ALKOXILO BAJO O TRIFLUOROMETILO; R (AL CUADRADO) Y R ELEVADO 3, QUE PUEDEN SER LAS MISMAS O DISTINTAS, CADA UNA DE ELLAS REPRESENTA UN ATOMO DE HIDROGENO O DE HALOGENO, UN GRUPO ALCALINO BAJO, UN GRUPO ALKOXILO BAJO, UN GRUPO DE ALKILTIO BAJO, TRIFLUOROMETILO O TRIFLUOROMETOXILO; R ELEVADO 4 REPRESENTA CARBOXILO QUE PUEDE ESTERIFICARSE OPCIONALMENTE; Y X REPRESENTA OXIGENO O AZUFRE; Y LOS PROCESOS PARA LA PRODUCCION DEL MISMO, ASI COMO UN COMPUESTO PARA EL TRATAMIENTO DE LAS COMPLICACIONES ASOCIADAS CON LA DIABETES Y DE UN INHIBIDOR DE LA REDUCTASA ALDOSA QUE COMPRENDE DICHO COMPUESTO.
ES91122330T 1990-12-27 1991-12-27 Derivados del acido 1,4-benzotiazina-2-acetico, procedimientos para su produccion y su uso. Expired - Lifetime ES2085950T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP41531690 1990-12-27
JP21934691 1991-08-06

Publications (1)

Publication Number Publication Date
ES2085950T3 true ES2085950T3 (es) 1996-06-16

Family

ID=26523070

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91122330T Expired - Lifetime ES2085950T3 (es) 1990-12-27 1991-12-27 Derivados del acido 1,4-benzotiazina-2-acetico, procedimientos para su produccion y su uso.

Country Status (10)

Country Link
US (1) US5252571A (es)
EP (1) EP0492667B1 (es)
JP (1) JP2729430B2 (es)
KR (1) KR0156581B1 (es)
AU (1) AU634109B2 (es)
CA (1) CA2058398C (es)
DE (1) DE69118850T2 (es)
DK (1) DK0492667T3 (es)
ES (1) ES2085950T3 (es)
IE (1) IE914455A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005647A1 (fr) * 1992-08-31 1994-03-17 Santen Pharmaceutical Co., Ltd. Derive de 3-oxo-1,4-benzothiazine
JPH06279453A (ja) * 1993-03-29 1994-10-04 Green Cross Corp:The ピリドチアジン酢酸誘導体，その製法及びその用途
US5556841A (en) * 1994-02-04 1996-09-17 Santen Pharmaceutical Co., Ltd. Thiazine or thiomorpholine derivatives
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
JP2003119142A (ja) * 1997-03-31 2003-04-23 Mitsubishi Pharma Corp 糖化蛋白変性物質生成阻害剤
WO2000076995A1 (fr) * 1999-06-14 2000-12-21 Mitsubishi Pharma Corporation Procede de preparation de derives de l'acide (-)-1,4-benzothiazine-2-acetique
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
AU2012249240A1 (en) * 2011-04-29 2013-11-07 Icahn School Of Medicine At Mount Sinai Kinase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1453465A (fr) * 1965-08-11 1966-06-03 Kuhlmann Ets Nouveaux antiozones
US3503965A (en) * 1967-12-01 1970-03-31 American Home Prod Derivatives of 1,4-benzothiazine
US3910904A (en) * 1974-08-12 1975-10-07 Monsanto Co 2-Substituted methylene-3,4-dihydro-3-oxo-2H-1,4-benzothiazine-4-acetic acid and esters thereof
IE58312B1 (en) * 1984-05-18 1993-09-08 Union Pharma Scient Appl Heterocyclic derivatives, processes for their preparation and drugs in which they are present, which are useful especially as aldose reductase inhibitors
AU602641B2 (en) * 1986-04-17 1990-10-18 Senju Pharmaceutical Co., Ltd. Thiolactam-N-acetic acid derivatives, their production and use

Also Published As

Publication number Publication date
CA2058398A1 (en) 1992-06-28
AU9004591A (en) 1992-07-09
AU634109B2 (en) 1993-02-11
US5252571A (en) 1993-10-12
EP0492667A1 (en) 1992-07-01
DK0492667T3 (da) 1996-07-08
DE69118850D1 (de) 1996-05-23
IE914455A1 (en) 1992-07-01
KR0156581B1 (en) 1998-11-16
JP2729430B2 (ja) 1998-03-18
CA2058398C (en) 2000-02-15
KR920012056A (ko) 1992-07-25
EP0492667B1 (en) 1996-04-17
DE69118850T2 (de) 1997-01-09
JPH0592961A (ja) 1993-04-16

Similar Documents

Publication Publication Date Title
ES8401970A1 (es) Un procedimiento para la preparacion de derivados de benzoisotiazol y benzoisoxazol piperazina.
ES2051719T3 (es) Un procedimiento para producir un compuesto de benzoilurea.
ES8401971A1 (es) Procedimiento para la preparacion de nuevos 6,11-dihidro-dibenzo-(b,e)-tiepin-11-n-alcohilnorescopin-eteres.
ES2053258T3 (es) Fungicidas.
PE10290A1 (es) Procedimiento de preparacion de derivados de benzotriazol
ES2040715T3 (es) Derivados de pirimidina, su fabricacion y los medicamentos que los contienen.
ES474592A1 (es) Procedimiento para la preparacion de derivados de imidazoli-nina
ES2003651A6 (es) Un procedimiento para la preparacion de derivados de 8-tia-1,6-diazabiciclo (4,3,0)-nonano.
ES2028857T3 (es) Procedimiento para la preparacion de derivados de amino-tiazol y amino-oxazol.
ES8601992A1 (es) Procedimiento para preparar 2-fenil-imidazoles
GT199900011A (es) Nuevos derivados del acido dihidroxihexanoico
ES2059416T3 (es) 1,4-dihidropiridina-enantiomeros.
ES8702914A1 (es) Procedimiento para preparar nuevas pirrolidina-2,5-dionas espiroenlazadas
ES8604922A1 (es) Procedimiento para la preparacion de n-piridilindoles
ES2045219T3 (es) Procedimiento para la preparacion de derivados del acido fenoxicarboxilico.
ES2075004T3 (es) Derivados de pirimidina, procedimientos para su produccion y composiciones herbicidas que los contienen.
ES2051954T3 (es) 2-aminotiazoles substituidos.
ES2128554T3 (es) Nuevos derivados del acido glutamico, procedimiento para su preparacion y su utilizacion como medicamentos para el aumento de la memoria y aprendizaje.
ES8106713A1 (es) Procedimiento para la preparacion de n-aril-n-acil-3-amino- oxazolidin-2-onas
ES8504192A1 (es) Procedimiento para la preparacion de cis yno trans hidroxiiminooctahidroindolo(2,3-a)-quinolizina racemicos (como divisional de la solicitud de patente de invencion num. 513.016, presentada el 11 de junio de 1982)
ES2060250T3 (es) Procedimiento para producir beta-caroteno y compuestos intermedios utiles para el procedimiento.
ES2038708T3 (es) Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
ES2061532T3 (es) Derivados sustituidos de acido piridina-2,4-dicarboxilico, procedimientos para su preparacion, utilizacion de los mismos, asi como medicamentos a base de estos compuestos.
ES2145480T3 (es) Amidas de acido carbamoilcarboxilico.
ES2090374T3 (es) Derivados de tiazolina, procesos para su preparacion y composiciones plaguicidas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 492667

Country of ref document: ES